The introduction of new agents and management strategies over the past decade has resulted in a major step change in treatment outcomes with deepening responses and increased survival for patients with multiple myeloma. In daily clinical practice, healthcare professionals are now faced with challenges including, optimal treatment sequencing and changing treatment goals. In light of this, a group of experts met to discuss diagnostic and treatment guidelines, examine current clinical practice, and consider how new clinical trial data may be integrated into the management of multiple myeloma in the future.

Insights on Multiple Myeloma Treatment Strategies / Mateos M.-V.; Ludwig H.; Bazarbachi A.; Beksac M.; Blade J.; Boccadoro M.; Cavo M.; Delforge M.; Dimopoulos M.A.; Facon T.; Geraldes C.; Goldschmidt H.; Hajek R.; Hansson M.; Jamroziak K.; Leiba M.; Masszi T.; Mendeleeva L.; O'Dwyer M.; Plesner T.; San-Miguel J.F.; Straka C.; Van De Donk N.W.C.J.; Yong K.; Zver S.; Moreau P.; Sonneveld P.. - In: HEMASPHERE. - ISSN 2572-9241. - ELETTRONICO. - 3:1(2019), pp. e163.0-e163.0. [10.1097/HS9.0000000000000163]

Insights on Multiple Myeloma Treatment Strategies

Cavo M.;
2019

Abstract

The introduction of new agents and management strategies over the past decade has resulted in a major step change in treatment outcomes with deepening responses and increased survival for patients with multiple myeloma. In daily clinical practice, healthcare professionals are now faced with challenges including, optimal treatment sequencing and changing treatment goals. In light of this, a group of experts met to discuss diagnostic and treatment guidelines, examine current clinical practice, and consider how new clinical trial data may be integrated into the management of multiple myeloma in the future.
2019
Insights on Multiple Myeloma Treatment Strategies / Mateos M.-V.; Ludwig H.; Bazarbachi A.; Beksac M.; Blade J.; Boccadoro M.; Cavo M.; Delforge M.; Dimopoulos M.A.; Facon T.; Geraldes C.; Goldschmidt H.; Hajek R.; Hansson M.; Jamroziak K.; Leiba M.; Masszi T.; Mendeleeva L.; O'Dwyer M.; Plesner T.; San-Miguel J.F.; Straka C.; Van De Donk N.W.C.J.; Yong K.; Zver S.; Moreau P.; Sonneveld P.. - In: HEMASPHERE. - ISSN 2572-9241. - ELETTRONICO. - 3:1(2019), pp. e163.0-e163.0. [10.1097/HS9.0000000000000163]
Mateos M.-V.; Ludwig H.; Bazarbachi A.; Beksac M.; Blade J.; Boccadoro M.; Cavo M.; Delforge M.; Dimopoulos M.A.; Facon T.; Geraldes C.; Goldschmidt H.; Hajek R.; Hansson M.; Jamroziak K.; Leiba M.; Masszi T.; Mendeleeva L.; O'Dwyer M.; Plesner T.; San-Miguel J.F.; Straka C.; Van De Donk N.W.C.J.; Yong K.; Zver S.; Moreau P.; Sonneveld P.
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/903567
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 31
  • ???jsp.display-item.citation.isi??? 31
social impact